Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazole

Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals

(2020) Katharina R. Beck et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Tributyltin and triphenyltin induce 11β-hydroxysteroid dehydrogenase 2 expression and activity through activation of retinoid X receptor α

(2020) Silvia G. Inderbinen et al.   TOXICOLOGY LETTERS

11β-hydroxysteroid dehydrogenases control access of 7β,27-dihydroxycholesterol to retinoid-related orphan receptor gamma

(2019) Katharina R. Beck et al.   JOURNAL OF LIPID RESEARCH

Enzymatic interconversion of the oxysterols 7β,25-dihydroxycholesterol and 7-keto,25-hydroxycholesterol by 11β-hydroxysteroid dehydrogenase type 1 and 2

(2019) Katharina R. Beck et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Drug-induced endocrine blood pressure elevation

(2019) Katharina R. Beck et al.   PHARMACOLOGICAL RESEARCH

Posaconazole Serum Drug Levels Associated with Pseudohyperaldosteronism

(2019) Minh-Vu H Nguyen et al.   CLINICAL INFECTIOUS DISEASES

Target quantification of azole antifungals and retrospective screening of other emerging pollutants in wastewater effluent using UHPLC –QTOF-MS

(2019) Hailemariam Abrha Assress et al.   ENVIRONMENTAL POLLUTION

Posaconazole-Induced Pseudohyperaldosteronism

(2018) Kevin Kuriakose et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Refractory Hypokalemia from Syndrome of Apparent Mineralocorticoid Excess on Low-Dose Posaconazole

(2018) Travis Wassermann et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Itraconazole induced hypertension and hypokalemia: Mechanistic evaluation

(2018) Wesley J. Hoffmann et al.   MYCOSES

Cilia-Associated Oxysterols Activate Smoothened

(2018) David R. Raleigh et al.   MOLECULAR CELL

Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency

(2017) Mabel Yau et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor

(2017) Maud Voisin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

(2013) G. Madhavi Sastry et al.   JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

The Anabolic Androgenic Steroid Fluoxymesterone Inhibits 11 -Hydroxysteroid Dehydrogenase 2-Dependent Glucocorticoid Inactivation

(2012) C. Furstenberger et al.   TOXICOLOGICAL SCIENCES

Species-specific differences in the inhibition of human and zebrafish 11β-hydroxysteroid dehydrogenase 2 by thiram and organotins

(2012) Arne Meyer et al.   TOXICOLOGY

Homology modeling and structural analysis of 11β-hydroxysteroid dehydrogenase type 2

(2011) Hideaki Yamaguchi et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Tissue-specific modulation of mineralocorticoid receptor function by 11β-hydroxysteroid dehydrogenases: An overview

(2011) Alex Odermatt et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Maternal prenatal licorice consumption alters hypothalamic–pituitary–adrenocortical axis function in children

(2010) Katri Räikkönen et al.   PSYCHONEUROENDOCRINOLOGY

Maternal Licorice Consumption and Detrimental Cognitive and Psychiatric Outcomes in Children

(2009) K. Raikkonen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension

(2009) Paolo Ferrari   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE